MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Bupp steps down as Neoprobe CEO | Personnel moves

Bupp steps down as Neoprobe CEO | Personnel moves

By

MassDevice.com Personnel Moves

Neoprobe Corp. (NYSE Amex:NEOP) is getting a new chief executive and, perhaps, a new board member.

The Dublin, Ohio-based cancer diagnostics firm announced that CEO David Bupp will be replaced by chief development officer Mark Pykett on April 15.

Bupp will remain on the company’s board, while Pykett will be nominated for a seat, according to Neoprobe. The board room moves could be significant because Platinum-Montaur Life Sciences, the company’s largest investor, nominated its own choices for the board last week saying it "reserve[s] the right to solicit proxies to see that these candidates are added" to the board in a regulatory filing.

Neoprobe CFO Brent Larson said that three seats on the company’s seven-member board are up for re-election this year and that the company is open to replacing the three current directors. He said he believes that New York-based Platinum simply wants Neoprobe to continue adding new expertise to its board as the company evolves and looks to get its first drug on the market.

The company continues to march toward FDA approval of what it calls its “game-changing” radiopharmaceutical, Lymphoseek. And, evidence suggests, there’s a healthy amount of investor interest in the company. Neoprobe’s shares are up a whopping 77 percent on the year and the company says it’s hitting major clinical milestones, such as reaching the accrual goal of a Phase III study of Lymphoseek last month.

company officials last week said they expect to file a New Drug Application with the Food & Drug Administration for Lymphoseek next quarter, but Pykett revealed today that the company is again delaying the application. Once approved, Neoprobe could begin marketing Lymphoseek and start raking in sales. The company estimates Lymphoseek’s market value at $450 million.

Pykett said the company will delay the filing until the third quarter because it needed to enroll additional patients in a phase 3 clinical trial of Lymphoseek. Those patients are now enrolled and Neoprobe said it expects to publicly announce top-line data from the trial in May and full data in June.

NEOP shares dropped more than 7 percent to close at $3.95 a piece.

Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.

  • Jerry Shay joins Life Length as scientific advisor
    Life Length the new biotechnology company that measures the length of telomeres, announced that Jerry Shay has been appointed as a scientific advisor.
    Read more

  • Digital Assent expands leadership team
    Digital Assent has expanded its leadership team to meet the rapidly growing demand for its award-winning PatientPad solution. The PatientPad is a self-service patient check-in and education solution designed to automate the patient intake process and deliver targeted health information to interested patients while they wait. The company has added five key executives to its sales, business development, operations and product development teams.
    Read more

  • Joslin Diabetes Center taps John Brooks as CEO
    Joslin Diabetes Center has appointed John L. Brooks, III, a well-known leader in the life sciences industry, as President and Chief Executive Officer.
    Read more

  • LipoScience taps Robert Greczyn Jr. and Woodrow Myers for board
    LipoScience Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance (NMR) technology, announced that Robert Greczyn Jr. and Dr. Woodrow Myers Jr. have joined the company’s board. Brooks became Chairman of Joslin’s Board in May 2010. He will leave that role to take the chief executive position. He is replacing Kenneth E. Quickel, Jr., M.D., who retired as Joslin’s President and CEO in October 2010.
    Read more

  • Delcath expands board with appointment of Gabriel Leung
    Delcath Systems Inc. (NSDQ:DCTH) appointed of Gabriel Leung, M.Sc. to the company’s expanded board, effective immediately. The company increased the size of its board from seven to eight and appointed Mr. Leung to fill this new vacancy. Mr. Leung will serve as a Class III director with a term expiring at the 2012 annual stockholder meeting.
    Read more

  • Golden Meditech chairman increases stake
    Golden Meditech Holdings Ltd. (801.HK; 910801.TW) wishes to announce that the Group’s Chairman, KAM Yuen and his family has purchased 11.532 million shares of the company on March 29 & 30, 2011, at the average price of HK$1.3152 per share via a representative holding company, as per disclosed to the Hong Kong Exchanges and Clearings Ltd. As a result of which, Kam and family have increased their interest in the company from 19.88% to 20.49%.
    Read more

  • Clive Zickel joins Magnetecs as CFO
    Magnetecs Corp., a designer and manufacturer of robotic catheterization control systems for minimally invasive surgical procedures, today reported that Clive Zickel has joined the company as CFO.
    Read more

  • Minnetronix appoints Lisa Lenz as controller
    Minnetronix Inc., a St. Paul-based medical device design and manufacturing firm, recently announced that Lisa Lenz has joined the company as controller.
    Read more

  • Topera adds Dr. Eric Prystowsky to management board
    Topera Medical, a developer of mapping systems that help identify the electrical source of cardiac arrhythmias, today announced the addition of Eric Prystowsky, MD, FHRS, to the company’s management advisory board
    Read more

  • Medifocus appoints Ernie Eves to board
    Medifocus Inc. (OTC:MDFZF.PK) (TSXV:MFS) a medical device company currently in Phase III clinical studies for the treatment of Breast Cancer, announced the appointment of Ernie Eves, QC, to its board.
    Read more

  • Cleveland HeartLab appoints Glenn Gershon VP
    Cleveland HeartLab LLC (CHL) appointed of Glenn Gershon as vice president of clinical laboratory operations and research and development.
    Read more

  • MEDRAD taps new interventional business head
    MEDRAD Inc. announced that Jack Darby joined the company as vice president of MEDRAD Interventional. In his new role, Darby will act as general manager of both the diagnostic and therapeutic lines of the business on a global scale, and will also join MEDRAD’s executive leadership team.
    Read more

  • Novella Clinical names director of marketing
    Novella Clinical Inc. announced Jessica Cunningham has joined the company as director of marketing. In this new role Cunningham will have executive oversight of all global marketing and communication for both Novella Clinical and Novella Clinical Resourcing.
    Read more

  • Alphatec Spine adds of Leslie Cross to board
    Alphatec Holdings Inc. (NSDQ:ATEC) announced the addition of Leslie Cross to its board. This appointment increases Alphatec Spine’s board in size from nine directors to ten, and increases the number of independent directors from five to six.
    Read more

  • ZOLL Medical Corp. elects Judith Pelham to board
    ZOLL Medical Cor. (NSDQ:ZOLL), a manufacturer of medical devices and related software solutions, announced that Judith Pelham was elected to its board at the company’s annual meeting on February 10. She replaces Daniel Mulvena who retired after serving on the board since 1998.
    Read more

Material from MedCity News was used in this report.

In case you missed it

RSS From Medical Design & Outsourcing

  • Forecasting the future of urology with Boston Scientific’s Meghan Scanlon
    Meghan Scanlon, Boston Scientific’s president of urology and pelvic health, discusses the field and the challenges and opportunities ahead. The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field, said Meghan Scanlon, SVP and president of urology and pelvic health at Boston Scientific (NYSE:BSX) That… […]
  • Women researchers receive a fraction of funding from the world’s biggest medtech companies
    The gender divide in medtech extends beyond leadership and into funding for investigational studies by U.S. physicians. Only 6.7% of physicians who received research payments from the world’s largest medical device companies in 2020 were women, according to an analysis of Medical Design & Outsourcing’s Big 100 list of medtech companies and CMS Open Payments… […]
  • Pentax Medical expands Vizient contract to include pediatric endoscopes
    Pentax Medical today announced it has expanded its contract with Vizient to include pediatric endoscopes. The contract will give Pentax Medical the ability to offer endoscopes to Vizient member hospitals through the Vizient Pediatric Program. The agreement also includes other value-added offerings, education opportunities and best practices. Get the full story on our sister site,… […]
  • Hologic plans to buy Bolder Surgical for $160M
    Hologic Inc. (NSDQ:HOLX) has a $160 million deal to acquire Bolder Surgical, a developer and manufacturer of advanced energy vessel sealing surgical devices. It’s the latest deal by Hologic, which has been spending COVID-19 test revenue generated by its diagnostics business on acquisitions across the company’s business lines, as CFO Karleen Oberton and CEO Steve MacMillan… […]
  • Koya Medical reports positive early results in Dayspring lymphedema trial
    Koya Medical this week announced positive results from a small, ongoing trial comparing its Dayspring compression treatment for lymphedema to a traditional pneumatic compression pump. The Oakland, California-based company secured FDA 510(k) clearance for the device last month, saying it was the first such approval for an active compression treatment enabling movement and mobility with… […]
  • OneProjects raises $17M to advance 4D cardiac imaging
    Irish-German cardiac imaging startup OneProjects today announced $8 million in Series A2 funding and two grants totaling $9 million. The company will use the new funds to complete product development, conduct clinical trials, gain FDA clearance and prepare for U.S. commercialization of the first product developed from its proprietary 4D cardiac imaging platform, Verafeye. The… […]
  • Women in Medtech 2021: Lindsay Fleming, Avient Corp. Commercial Manager, Healthcare — Color & Additives
    Lindsay Fleming is the Healthcare Commercial Manager for the Color & Additives division at Avient Corporation, a premier provider of specialty polymer formulations, color and additive systems, packaging solutions, and polymer distribution. She has been with the company for over 7 years and oversees the commercial growth development of the healthcare segment. She focuses on… […]
  • Women in Medtech 2021: Sarah Ehrlich, Argon Medical Devices Sustaining Mechanical Engineer
    Sarah Ehrlich, sustaining mechanical engineer at Argon Medical Devices, holds a B.S in mechanical engineering from the University of Texas at Tyler. “My parents knew I would become an engineer before I did,” she said. “Growing up, I was the big sister who put back together whatever my younger siblings decided to tear apart. I… […]
  • Four questions with AdvaMed’s Jen Brearey
    Jen Brearey is AdvaMed’s chief financial officer and chief operating officer, as well as executive director for the association’s inclusion diversity programs, which includes the industry initiative AdvaMed Advance and AdvaMed’s Women’s Executive Network. Ahead of our annual Women in Medtech edition of Medical Design & Outsourcing, we asked Brearey to share her expertise on gender… […]
  • Life Spine wins FDA clearance for ProLift micro expandable spacer
    Life Spine announced that it received FDA clearance to market its ProLift micro expandable spacer system for supporting micro-invasive procedures. Huntley, Illinois-based Life Spine designed its ProLift micro to support procedures ranging from endoscopic TLIFs to MIS TLIFs/PLIFs. The platform includes an 8mm width, self-locking expansion at any height (between 8mm and 16mm) to suit… […]
  • Achieve More with Medical Device Training and Certifications
    Any medical professional that deals with complex devices on a regular basis can benefit greatly from a wide range of medical device courses offered by The Center for Professional Innovation and Education (CfPIE). Each course offered is designed to advance your career under the instruction of trained, experienced, and actively practicing professionals in the field.… […]

Leave a Reply